Medicinal Products

Azacitidin Sandoz 25 mg/ml prašak za suspenziju za injekciju

Name Azacitidin Sandoz 25 mg/ml prašak za suspenziju za injekciju
Marketing Authorisation Number HR-H-152619540
Active Substance azacitidin
Composition svaka bočica s praškom sadrži 100 mg azacitidina, nakon rekonstitucije jedan ml suspenzije sadrži 25 mg azacitidina
Pharmaceutical Form prašak za suspenziju za injekciju
Manufacturer Pharmadox Healthcare Limited, Paola, Malta
Lek Pharmaceuticals d.d., Ljubljana, Slovenija
Salutas Pharma GmbH, Barleben, Njemačka
Marketing Authorisation Holder Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska
Marketing Authorisation Date 29.01.2025
MA Period of Validity unlimited
Classification Number UP/I-530-09/24-02/82
Registration Number 381-12-01/70-25-06
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to restricted medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01BC07
Marketing status Marketed
Shortage status No shortage
SmPC download
PL download
Public Assessment Report download
Summary of risk management plan download

Packaging

Back